BioSpace News Archive

Business

CONMED Corporation Announces Quarterly Cash Dividend - Nov. 28, 2017

The company declared a quarterly cash dividend of $0.20 per share, payable on January 5, 2018 to all shareholders of record as of December 15, 2017.

November 27, 2017

·

1 min read

Deals

SVA Consulting and Bio-Ops, Inc. Announce Merger

SVA Consulting, LLC and Bio-Ops, Inc. have joined forces under a new Emerging Life Science (ELS) consulting brand, SVA Bio-Ops.

November 27, 2017

·

2 min read

Bio NC

IQVIA Announces Launch of Secondary Public Offering and Repurchase of Common Stock

The Repurchase will be completed outside IQVIA’s existing share repurchase program, under which IQVIA has approximately $195 million of remaining availability.

November 27, 2017

·

3 min read

Drug Development

Pivotal Trial Data Support Potential of Seno Medical Instruments’ Imagio Opto-Acoustic Breast Imaging System in Reducing False Positive Breast Examinations and Benign Biopsies

The study found that OA/US was more specific than device gray-scale ultrasound alone in differentiating malignant from benign breast lesions and was non-inferior to US with respect to sensitivity.

November 27, 2017

·

6 min read

Drug Development

Medigene AG: Patient Recruitment Completed for Phase I/II DC Vaccine Trial in AML

The completion of the study, as previously announced, is expected in 2019 after a treatment period of two years for all patients.

November 27, 2017

·

4 min read

Business

Medtronic Launches New Telehealth Solutions in Support of U.S. Department of Veterans Affairs National Contract

MCMS has partnered with the VA since 2011, serving more than 310,000 unique veterans since that time.

November 27, 2017

·

3 min read

Business

PMD Solutions Selected as Innovative Respiratory Device Leader to Join the NHS Innovation Accelerator Programme

Now entering its third year, the NIA is an NHS England initiative delivered in partnership with England’s 15 AHSNs and focused exclusively on identifying and partnering with only the top leading healthcare pioneers in the market.

November 27, 2017

·

3 min read

Drug Development

Eloxx Pharmaceuticals Announces First Patient Dosed in Phase Ib Clinical Trial

The trial is being run in Belgium, and data are expected at the end of the fourth quarter 2018.

November 27, 2017

·

3 min read

Business

GENFIT: Contributing Significantly to the European LITMUS Initiative on NASH Biomarkers

LITMUS (The Liver Investigation: Testing Marker Utility in Steatohepatitis) is a European consortium that brings together clinicians and scientists from prominent academic centers across Europe.

November 27, 2017

·

8 min read

Pharm Country

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Nov. 27, 2017

In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed’s Compensation Committee and made as a material inducement to each employee’s entry into employment with the Company.

November 27, 2017

·

1 min read